AAAlexis Antonucci

Alexis Antonucci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexis Antonucci has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Alexander R. Lucas

    Department of Internal Medicine—Cardiology Virginia Commonwealth University Richmond Virginia USA

    1 shared publication
  • Alexandra Marshall

    Affiliation Department of Internal Medicine, Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America

    1 shared publication
  • Amy Ladd

    Affiliation Department of Internal Medicine, Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, United States of America

    1 shared publication
  • Anna E. Gibson

    Department of Surgery, Virginia Commonwealth University, Richmond, VA

    1 shared publication
  • Harry Douglas Bear

    Division of Surgical Oncology, Department of Surgery and the Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA

    1 shared publication
  • Jeremy Via

    Department of Kinesiology and Health Sciences Virginia Commonwealth University Richmond Virginia USA

    1 shared publication

Latest Publications

  • Open Access

    Physical activity is associated with exercise capacity among patients undergoing chemotherapy: A pilot randomized controlled trial

    by Alexis Antonucci, Alexander R. Lucas, Juliana Costa, Sam Norton, Peter Brubaker, Shannon Mihalko, Alexandra Marshall, Jeremy Via, R. Lee Franco, Amy Ladd, et al.

    Introduction: Exercise intolerance is common among cancer patients undergoing active treatments. We conducted a pilot study in patients receiving potentially cardiotoxic therapies to investigate the impact of participation in a 6-month physical activity intervention (PAI) versus a healthy lifestyle education control intervention (HLI) on accelerometer-derived measures of PA (steps/day or minutes of moderate to vigorous PA [MVPA]/week) and whether these measures were associated with submaximal exercise capacity (6-minute walk distance [6MWD]). Methods: Participants with breast cancer or lymphoma (n = 33) were randomized (2:1) into PAI or HLI groups. Exercise training was patient-centered, tailored by treatment and functional status. Objective assessments of PA (steps/day, MVPA/week), and submaximal exercise capacity (6MWD) were completed at baseline, 3-, and 6-months. Descriptive statistics were used to examine changes in PA and 6MWD. T-tests were used to examine differences in 6MWD between groups at 3- and 6-months. Results: At baseline, 27 participants in the PAI (n = 20) and HLI (n = 7) groups who completed baseline and at least 1 follow up visit, had a mean age of 53 (range: 23–76) vs 56 (range: 40–77) years, took on average 8,330 ± 2520 vs 7800 ± 3830 steps/day, did an average of 133 ± 44 vs 109 ± 87 minutes of MVPA/week, and had a mean 6MWD of 496 ± 94 vs 440 ± 18 meters, respectively. At 3- and 6-months there was a 87m and 76m difference in 6MWD by intervention group. A correlation analysis did find significant associations between steps/day (r = 0.51, p = .04) and 6MWD at 3-months. Conclusions: Baseline data indicate that, on average, our study sample was close to meeting the PA guidelines. Unexpectedly, both groups maintained their activity levels up to 3- and 6-months. Submaximal exercise capacity (6MWD) was also maintained (with a clinically meaningful but not statistically significant relative benefit in the PAI) suggesting higher PA levels may associate with reduced exercise intolerance after anthracycline therapy.